We have one long-term equity incentive plan, the Restated Plan. We have reserved for issuance under the Restated Plan 23,100,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units and stock appreciation rights.

Our stock-based compensation consists of various types of awards, each accounted for separately. There is no overlap between our stock options, restricted stock awards (“RSAs”) and restricted stock units (“RSUs”), performance stock units (“PSUs”), and performance stock options (“PSOs”).

Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over 3 to 5 years and expire 5 to 10 years from the date of grant.


Outstanding Options Under the 2006 Plan	Shares	Weighted Average Exercise price Per Common Share		Weighted Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value (in thousands)
Balance, December 31, 2025	994,874	$	19.11
Granted	—	—
Exercised	(163,557)	15.36
Canceled, forfeited or expired	(133)	81.54
Balance, September 30, 2026	831,184	19.83		4.66	$	40,818
Exercisable at September 30, 2026	746,195	19.89		4.47	$	36,603

Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on September 30, 2026 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on September 30, 2026. As of September 30, 2026, total unrecognized stock-based compensation expense related to non-vested employee awards was $0.2 million which is expected to be recognized over a weighted average period of approximately 0.4 years.

The Restated Plan permits the award of RSAs and RSUs. The following summarizes all unvested RSA and RSU activities for the nine months ended September 30, 2026:


	RSAs and RSUs	Weighted-Average Remaining Contractual Term (Years)	Weighted-Average Fair Value per Share
RSAs and RSUs unvested at December 31, 2025	893,385		$	58.23
Granted	923,474		$	71.85
Vested	(762,178)		$	62.32
Forfeited or Canceled	(63,346)		$	59.91
RSAs and RSUs unvested at September 30, 2026	991,335	0.98	$	68.01

In October 2024, we granted certain employees PSUs with a target award of 35,522 shares of our common stock. The PSUs vest in five equal annual installments on each anniversary of the grant date, subject to continued service and achievement of a performance condition established at the grant date. The performance condition will be measured over a performance period ending no later than the seventh anniversary of the grant date. The number of shares earned may range from 0% to 100% of the target award based on actual performance results. As of September 30, 2026, based on performance achieved to date, all 35,522 shares are expected to vest.

In January 2023, we granted certain executive officers PSUs with a target award of 60,685 shares of our common stock and a grant-date fair value of $18.64 per share. The number of shares earned could range from 0% to 200% of target, based on achievement of a performance condition, as determined by the board of directors, for the period January 1, 2023 through December 31, 2023. In March 2024, the board determined that the performance condition was achieved at the

maximum level, and 121,370 shares (200% of target) were earned. These were settled as 121,370 shares of RSUs. The earned awards vested in two equal installments on March 10, 2025 and March 10, 2026, subject to continued service. As of September 30, 2026, all 121,370 shares had vested.

Of the 23,100,000 shares of common stock reserved for issuance under the Restated Plan, at September 30, 2026, there remain approximately 4,328,156 shares available under the Restated Plan for future issuance.